Literature DB >> 9204896

Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis.

P C Maisonpierre1, C Suri, P F Jones, S Bartunkova, S J Wiegand, C Radziejewski, D Compton, J McClain, T H Aldrich, N Papadopoulos, T J Daly, S Davis, T N Sato, G D Yancopoulos.   

Abstract

Angiogenesis is thought to depend on a precise balance of positive and negative regulation. Angiopoietin-1 (Ang1) is an angiogenic factor that signals through the endothelial cell-specific Tie2 receptor tyrosine kinase. Like vascular endothelial growth factor, Ang1 is essential for normal vascular development in the mouse. An Ang1 relative, termed angiopoietin-2 (Ang2), was identified by homology screening and shown to be a naturally occurring antagonist for Ang1 and Tie2. Transgenic overexpression of Ang2 disrupts blood vessel formation in the mouse embryo. In adult mice and humans, Ang2 is expressed only at sites of vascular remodeling. Natural antagonists for vertebrate receptor tyrosine kinases are atypical; thus, the discovery of a negative regulator acting on Tie2 emphasizes the need for exquisite regulation of this angiogenic receptor system.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9204896     DOI: 10.1126/science.277.5322.55

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  877 in total

Review 1.  Angiogenesis.

Authors:  C D Kontos; B H Annex
Journal:  Curr Atheroscler Rep       Date:  1999-09       Impact factor: 5.113

Review 2.  Mechanisms of tumor angiogenesis and therapeutic implications: angiogenesis inhibitors.

Authors:  H Malonne; I Langer; R Kiss; G Atassi
Journal:  Clin Exp Metastasis       Date:  1999-02       Impact factor: 5.150

Review 3.  Physiology of angiogenesis.

Authors:  H Kurz
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

4.  The orphan nuclear receptor COUP-TFII is required for angiogenesis and heart development.

Authors:  F A Pereira; Y Qiu; G Zhou; M J Tsai; S Y Tsai
Journal:  Genes Dev       Date:  1999-04-15       Impact factor: 11.361

Review 5.  Science, medicine, and the future. Antivascular therapy: a new approach to cancer treatment.

Authors:  A J Hayes; L Y Li; M E Lippman
Journal:  BMJ       Date:  1999-03-27

Review 6.  Role of hematopoietic stem cells in angiogenesis.

Authors:  T Suda; N Takakura
Journal:  Int J Hematol       Date:  2001-10       Impact factor: 2.490

Review 7.  Vascular growth factors in cerebral ischemia.

Authors:  S D Croll; S J Wiegand
Journal:  Mol Neurobiol       Date:  2001 Apr-Jun       Impact factor: 5.590

8.  Sugar creates a sticky business: round up the usual suspects.

Authors:  James T Rosenbaum
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

9.  Impaired function of the Tie-2 receptor contributes to vascular leakage and lethality in anthrax.

Authors:  Chandra C Ghosh; Aditi Mukherjee; Sascha David; Ulla G Knaus; Deborah J Stearns-Kurosawa; Shinichiro Kurosawa; Samir M Parikh
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-04       Impact factor: 11.205

10.  Excess Maternal Thyroxine Alters the Proliferative Activity and Angiogenic Profile of Growth Cartilage of Rats at Birth and Weaning.

Authors:  Lorena Gabriela Rocha Ribeiro; Juneo Freitas Silva; Natália de Melo Ocarino; Cíntia Almeida de Souza; Eliane Gonçalves de Melo; Rogéria Serakides
Journal:  Cartilage       Date:  2016-12-28       Impact factor: 4.634

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.